NewAmsterdam Pharma (NAMS) Debt Ratio (2022 - 2026)

NewAmsterdam Pharma has disclosed Debt Ratio across 5 years of filings, most recently posting 0.07 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.07, up 138.53% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.07 (up 138.53% YoY), and the FY2025 annual result was 0.07, up 71.59% from the prior year.
• Debt Ratio came in at 0.07 for Q1 2026 at NewAmsterdam Pharma, down from 0.07 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.07 in Q4 2025 to a low of 0.0 in Q2 2023.
• The 5-year median for Debt Ratio is 0.04 (2024), against an average of 0.04.
• Across the five-year window, Debt Ratio surged 321260.74% in 2024 and tumbled 57.53% in 2025, its largest moves.
• NewAmsterdam Pharma's Debt Ratio stood at 0.01 in 2022, then soared by 395.3% to 0.04 in 2023, then gained by 19.77% to 0.04 in 2024, then jumped by 71.59% to 0.07 in 2025, then decreased by 7.91% to 0.07 in 2026.
• The last three Debt Ratio figures came in at 0.07 (Q1 2026), 0.07 (Q4 2025), and 0.06 (Q3 2025), per Business Quant data.